Advances on drug therapy for KRAS<sup>G12C</sup>-mutant non-small-cell lung cancer.

Transl Oncol · 2026 · PMC12828744 · PMID 41529383

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, these exploratory analyses did not reach statistical significance[ 17 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Advances on drug therapy for KRAS&lt;sup&gt;G12C&lt;/sup&gt;-mutant non-small-cell lung cancer.

The sentences

Advances on drug therapy for KRAS<sup>G12C</sup>-mutant non-small-cell lung cancer.